Factor VII gene haplotypes and risk of ischemic stroke

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1190-1192

  Funk, Marion ^a   Endler, Georg ^a   Lalouschek, Wolfgang ^a   Hsieh, Kety ^a   Schillinger, Martin ^a   Lang, Wilfried ^b   Mannhalter, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ALLELE; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PATHOGENESIS; WILD TYPE;

ACUTE DISEASE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FACTOR VII; FEMALE; HAPLOTYPES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33646913542     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.059360     Document Type: Article

References (20)

1. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
2. Lansbury AJ, Grant P, Catto AJ. Atherothrombotic risk factors in subjects with a family history of stroke. Cerebrovasc Dis 2002;14:153-60.
3. Redondo M, Watzke HH, Stucki B, Sulzer I, Demarmels Biasiutti F, et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler Thromb Vasc Biol 1999;19:1020-5.
4. Cortellaro M, Baldassarre D, Cofrancesco E, Tremoli E, Colombo A, Boschetti C, et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease. Stroke 1996;27:450-4.
5. He M, Wen Z, He X, Xiong S, Liu F, Xu J, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002;107:223-8.
6. Heywood DM, Carter A, Catto AJ, Bamford JM, Grant PJ. Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997;28:816-21.
7. Demarmels Biasiutti F, Berger D, Mattle HP, Lammle B, Wuillemin WA. Hemostatic risk factors in ischemic stroke. Thromb Haemost 2003;90: 1094-9.
8. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985;54:475-9.
9. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996;16:72-6.
10. la;4.25van't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 1999;93:3432-41.
11. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991;11:540-6.
12. Lang W, Lalouschek W, on behalf of the Vienna Stroke Study Group. The Vienna Stroke Registry: objectives and methodology. Wien Klin Wochenschr 2001;113:141-7.
13. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936-49.
14. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
15. Iacoviello L, Di Castelnuovo A, de Knijff P, D'Orazio A, Amore C, Arboretti R, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998;338:79-85.
16. Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996;119:119-27.
17. Kudaravalli R, Tidd T, Pinotti M, Ratti A, Santacroce R, Margaglione M, et al. Polymorphic changes in the 5′ flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost 2002;88:763-7.
18. Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Vicente V. Genetic polymorphisms of factor VII are not associated with arterial thrombosis. Blood Coagul Fibrinolysis 1998;9:267-72.
19. Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, et al. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost 2004;92:541-9.
20. Carew JA, Basso F, Miller GJ, Hawe E, Jackson AA, Humphries SE, et al. A functional haplotype in the 5′ flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost 2003;1:2179-85.